| S-33/1 |
The purinergic system cooperates with the algogenic factors
bradykinin and CGRP in modulating neuron/glia communication in mouse
trigeminal ganglia from wild type and R192Q Cav2.1 knock-in mice:
implications for basic mechanisms of migraine pain
S. Ceruti, G. Villa, M. Fumagalli, L. Colombo, G. Magni, M.
Zanardelli, E. Fabbretti, C. Verderio, AMJM. van den Maagdenberg, A. Nistri,
MP. Abbracchio (Milano, Trieste,
Leiden, Olanda) |
| S-33/2 |
Control of enteric neuromuscular functions by adenosine receptors
under normal conditions and in the presence of bowel inflammation
L. Antonioli, M. Fornai, R. Colucci, O. Awwad, M. Tuccori , A. Bin,
RM. Gaion, I. Castagliuolo, M.C. Giron,
C. Blandizzi (Pisa, Padova) |
| S-33/3 |
A3 adenosine receptors are overexpressed in pleura from patients with
mesothelioma and reduce malignant mesothelioma cell growth
K. Varani, F. Vincenzi, M. Targa, A. Stefanelli, M. Tognon, PA. Borea (Ferrara) |
| S-33/4 |
cAMP system inhibits EMT in MDCK cells and purine
receptor-mediated activity may represent a novel insight in the modulation of
this phenotypic conversion.
S. Romano, P. Giuliani, P. Ballerini, R. Ciccarelli, F.
Caciagli, P. Di Iorio (Chieti) |
| S-33/5 |
Adenosine receptor control of 3,4-methylenedioxymethamphetamine
(MDMA, ecstasy)-induced neurotoxicity and gliosis: differences between
adolescent and adult mice
L. Frau, A.S. Khairnar, M. Morelli (Cagliari) |
| S-33/6 |
Trophic activity of human P2X7 receptor splice variants
E. Adinolfi, AL. Giuliani, T.
Ricco, L. Raffaghello, V. Pistoia, F. Di Virgilio (Ferrara, Genova) |
| S-33/7 |
Expression and
function of the P2X7 purinergic receptor in peripheral blood
mononuclear cells from patients with Behçet’s disease
M. Castrichini, P.E. Lazzerini, P.L. Capecchi, R. Franceschini, A.
Gamberucci, M. Hammoud, A. Moramarco, M. Natale, E. Gianchecchi, C.
Montilli, G. Ricci , S. Zimbone, M. Galeazzi, F. Laghi Pasini (Siena) |
| S-33/8 |
Role of P2 receptors on CA1 neuronal impairment induced by oxygen
glucose deprivation: involvement of ERK1/2 activation.
A.M. Pugliese, C. Traini , G. Maraula , T. Mello, M.G.
Giovannini, E. Coppi, R. Volpini, G. Cristalli, F. Pedata (Firenze,
Camerino) |